Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | BRAF |
Variant | R506_K507insLLR |
Impact List | insertion |
Protein Effect | gain of function |
Gene Variant Descriptions | BRAF R506_K507insLLR results in the insertion of three amino acids in the protein kinase domain of the Braf protein between amino acids 506 and 507 (UniProt.org). R506_K507insLLR results in impaired Braf homodimerization and heterodimerization, confers resistance to RAF inhibitors, and leads to increased phosphorylation of Erk1/2 and downstream signaling, and foci formation in cultured cells (PMID: 34108213). |
Associated Drug Resistance | Y |
Category Variants Paths |
BRAF mutant BRAF act mut BRAF R506_K507insLLR |
Transcript | NM_004333.6 |
gDNA | chr7:g.140777090_140777091insAAGAAGCCT |
cDNA | c.1518_1519insCTTCTTAGG |
Protein | p.R506_K507insLLR |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_004333.5 | chr7:g.140777090_140777091insAAGAAGCCT | c.1518_1519insCTTCTTAGG | p.R506_K507insLLR | RefSeq | GRCh38/hg38 |
NM_001354609.1 | chr7:g.140777090_140777091insAAGAAGCCT | c.1518_1519insCTTCTTAGG | p.R506_K507insLLR | RefSeq | GRCh38/hg38 |
NM_001354609.2 | chr7:g.140777090_140777091insAAGAAGCCT | c.1518_1519insCTTCTTAGG | p.R506_K507insLLR | RefSeq | GRCh38/hg38 |
XM_047420769.1 | chr7:g.140777090_140777091insAAGAAGCCT | c.1518_1519insCTTCTTAGG | p.R506_K507insLLR | RefSeq | GRCh38/hg38 |
NM_001378468.1 | chr7:g.140777090_140777091insAAGAAGCCT | c.1518_1519insCTTCTTAGG | p.R506_K507insLLR | RefSeq | GRCh38/hg38 |
NM_004333.6 | chr7:g.140777090_140777091insAAGAAGCCT | c.1518_1519insCTTCTTAGG | p.R506_K507insLLR | RefSeq | GRCh38/hg38 |
NM_001378474.1 | chr7:g.140777090_140777091insAAGAAGCCT | c.1518_1519insCTTCTTAGG | p.R506_K507insLLR | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|